Genomic and Transcriptomic Landscape of Tumor Clonal Evolution in Cholangiocarcinoma

被引:3
|
作者
Chen, Geng [1 ]
Cai, Zhixiong [1 ]
Dong, Xiuqing [2 ]
Zhao, Jing [1 ]
Lin, Song [1 ]
Hu, Xi [1 ]
Liu, Fang-E [3 ]
Liu, Xiaolong [2 ]
Zhang, Huqing [1 ]
机构
[1] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian, Peoples R China
[2] Fujian Med Univ, Mengchao Hepatobiliary Hosp, United Innovat Mengchao Hepatobiliary Technol Key, Fuzhou, Peoples R China
[3] Xian Peihua Univ, Sch Med, Dept Nursing, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
cholangiocarcinoma; clonal evolution; sequencing; transcriptome; genome; CANCER-CELLS; CXCL9; OVEREXPRESSION; POPULATIONS; INFERENCE; FILAMIN; IFITM1;
D O I
10.3389/fgene.2020.00195
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Cholangiocarcinoma remained a severe threat to human health. Deciphering the genomic and/or transcriptomic profiles of tumor has been proved to be a promising strategy for exploring the mechanism of tumorigenesis and development, which could also provide valuable insights into Cholangiocarcinoma. However, little knowledge has been obtained regarding to how the alteration among different omics levels is connected. Here, using whole exome sequencing and transcriptome sequencing, we performed a thorough evaluation for the landscape of genome and transcriptome in cholangiocarcinoma and illustrate the alteration of tumor on different biological levels. Meanwhile, we also identified the clonal structure of each included tumor sample and discovered different clonal evolution patterns related to patients' survival. Furthermore, we extracted subnetworks that were greatly influenced by tumor clonal/subclonal mutations or transcriptome change. The topology relationship between genes affected by genomic/transcriptomic changes in biological interaction networks revealed that alteration of genome and transcriptome was highly correlated, and somatic mutations located on important genes might affect the expression of numerous genes in close range.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] The Genomic Landscape of Compensatory Evolution
    Szamecz, Bela
    Boross, Gabor
    Kalapis, Dorottya
    Kovacs, Karoly
    Fekete, Gergely
    Farkas, Zoltan
    Lazar, Viktoria
    Hrtyan, Monika
    Kemmeren, Patrick
    Koerkamp, Marian J. A. Groot
    Rutkai, Edit
    Holstege, Frank C. P.
    Papp, Balazs
    Pal, Csaba
    PLOS BIOLOGY, 2014, 12 (08)
  • [22] Xeno-MCL: Genomic, Transcriptomic and Pathologic Landscape Associated with Disease Progression, Clonal Evolution and Tissue Tropism in Patient-Derived Xenografts of Mantle Cell Lymphoma
    Jiang, Vivian Changying
    Zhang, Shaojun
    Zhao, Shuangtao
    Liu, Yang
    McIntosh, Joseph
    Wang, Linghua
    Wang, Michael
    BLOOD, 2020, 136
  • [23] Analysis of the genomic and transcriptomic landscape of chemoresistant multiple myeloma
    Ziccheddu, Bachisio
    Biancon, Giulia
    Dugo, Matteo
    Devecchi, Andrea
    De Philippis, Chiara
    Bagnoli, Filippo
    Maura, Francesco
    De Cecco, Loris
    Gimondi, Silvia
    Vendramin, Antonio
    Terragna, Carolina
    Martello, Marina
    Bagratuni, Tina
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    Cavo, Michele
    Sensi, Maria Luisa
    Carniti, Cristiana
    Montefusco, Vittorio
    Corradini, Paolo
    Bolli, Niccolo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E58 - E59
  • [24] Transcriptomic and genomic landscape of ovarian cancer stem cells
    Zehir, Ahmet
    Ertem, Server A.
    Moore, Malcolm A. S.
    CANCER RESEARCH, 2012, 72
  • [25] The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers
    Kazandjian, Suzanne
    Rousselle, Emmanuelle
    Dankner, Matthew
    Cescon, David W.
    Spreafico, Anna
    Ma, Kim
    Kavan, Petr
    Batist, Gerald
    Rose, April A. N.
    CANCERS, 2024, 16 (02)
  • [26] Genomic and transcriptomic landscape of human gastrointestinal stromal tumors
    Xie, Feifei
    Luo, Shuzhen
    Liu, Dongbing
    Lu, Xiaojing
    Wang, Ming
    Liu, Xiaoxiao
    Jia, Fujian
    Pang, Yuzhi
    Shen, Yanying
    Zeng, Chunling
    Ma, Xinli
    Tang, Daoqiang
    Tu, Lin
    Yang, Linxi
    Cheng, Yumei
    Luo, Yuxiang
    Xie, Fanfan
    Hou, Hao
    Huang, Tao
    Ni, Bo
    Zhuang, Chun
    Zhao, Wenyi
    Li, Ke
    Zheng, Xufen
    Bi, Wenbo
    Jia, Xiaona
    He, Yi
    Wang, Simin
    Cao, Hui
    Wu, Kui
    Wang, Yuexiang
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [27] Mutations, Bottlenecks, and Clonal Sweeps: How Environmental Carcinogens and Genomic Changes Shape Clonal Evolution during Tumor Progression
    Reeves, Melissa Q.
    Balmain, Allan
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2024, 14 (03):
  • [28] Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the 'NSCLC' of GI Oncology?
    Gupta, Amol
    Kurzrock, Razelle
    Adashek, Jacob J.
    CANCERS, 2023, 15 (05)
  • [29] EXPLORING THE GENOMIC, TRANSCRIPTOMIC, AND PROTEOMIC INTERSECTIONS IN CHOLANGIOCARCINOMA: A DRUG DISCOVERY APPROACH
    Malekpour, Mahdi
    Salarikia, Seyed Reza
    Golabi, Fahime
    Sheida, Fateme
    Kashkooli, Mohammad
    Midjani, Farzad
    Soleymanjahi, Saeed
    GASTROENTEROLOGY, 2024, 166 (05) : S763 - S764
  • [30] Analysis of genomic landscape and tumor evolution in astroblastoma by whole-genome sequencing
    Yamamoto, Ryo
    Nakashima, Takuma
    Sugihara, Yuriko
    Funakoshi, Yusuke
    Yajima, Hirohisa
    Tateishi, Kensuke
    Suzuki, Tomonari
    Saito, Ryuta
    Narita, Yoshitaka
    Nobusawa, Sumihito
    Suzuki, Hiromichi
    CANCER SCIENCE, 2024, 115 : 386 - 386